IGFBP4 Antikörper (AA 22-258)

Produktnummer ABIN3201236

Produktdetails anti-IGFBP4 Antikörper

Target: IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))

Bindungsspezifität: AA 22-258

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser IGFBP4 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Verwendungszweck: Monoclonal Antibody to Insulin Like Growth Factor Binding Protein 4 (IGFBP4)

Sequenz: MGHHHHHHSG SEF-DEAIHCPPC SEEKLARCRP PVGCEELVRE PGCGCCATCA LGLGMPCGVY TPRCGSGLRC YPPRGVEKPL HTLMHGQGVC MELAEIEAIQ ESLQPSDKDE GDHPNNSFSP CSAHDRRCLQ KHFAKIRDRS TSGGKMKVNG APREDARPVP QGSCQSELHR ALERLAASQS RTHEDLYIIP IPNCDRNGNF HPKQCHPALD GQRGKCWCVD RKTGVKLPGG LEPKGELDCH QLADSFRE

Spezifität: The antibody is a mouse monoclonal antibody raised against IGFBP4. It has been selected for its ability to recognize IGFBP4 in immunohistochemical staining and western blotting.

Kreuzreaktivität: Maus, Schwein, Ratte

Aufreinigung: Protein A + Protein G affinity chromatography

Immunogen: Recombinant Insulin Like Growth Factor Binding Protein 4 (IGFBP4) corresdonding to Asp22~Glu258 with N-terminal His Tag

Klon: A3

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise:

Western blotting: 0.5-2 μg/mL

Immunohistochemistry: 5-20 μg/mL

Immunocytochemistry: 5-20 μg/mL

Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.

Handhabung: Avoid repeated freeze/thaw cycles

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Haltbarkeit: 24 months

Details zu IGFBP4

Target: IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))

Andere Bezeichnung: Insulin Like Growth Factor Binding Protein 4 (IGFBP4 Produkte)

Synonyme: IGFBP4 antikoerper, igfbp4 antikoerper, BP-4 antikoerper, HT29-IGFBP antikoerper, IBP4 antikoerper, IGFBP-4 antikoerper, AI875747 antikoerper, Deb2 antikoerper, IGF-BP4 antikoerper, IBP-4 antikoerper, insulin like growth factor binding protein 4 antikoerper, insulin-like growth factor-binding protein 4 antikoerper, insulin-like growth factor binding protein 4 antikoerper, IGFBP4 antikoerper, LOC100136305 antikoerper, LOC100194498 antikoerper, igfbp4 antikoerper, Igfbp4 antikoerper

Hintergrund: BP4, HT29-IGFBP, IBP4

Pathways: WNT Signalweg, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process